NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
(855) 940-4867
Medically reviewed on by
Regional Medical Director Greater St. Louis
Taking care of your mental health is important under the best of circumstances, but it’s especially important during the COVID-19 pandemic.
In a survey conducted by the Centers for Disease Control and Prevention, more than 40% of respondents age 18 and older said they experienced depression, anxiety, or other mental health symptoms between April and June 2020.
As a result, there has been a corresponding increase in detrimental health effects. American adults responded in a Kaiser Family Foundation poll that they had problems sleeping (36% of participants), ate poorly (32%), turned to drugs or alcohol to cope (12%) and experienced a downturn in chronic health conditions (12%). These effects, and the toll they take, make it harder to stay healthy mentally and physically.
Additionally, a new meta-analysis published in JAMA Psychiatry reinforces the importance of taking care of your mental health. Not only does the stress of the pandemic take a toll on us, but the study found that there is also an increased risk of death among those with more serious mental health conditions. In essence, people with a mental health condition may be at higher risk of dying from COVID compared to people without those struggles. TMS can be a useful tool for supporting your mental health during COVID and enhancing your overall well-being.
The JAMA Psychiatry study analyzed data from seven countries on three continents: Denmark, France, Israel, South Korea, Spain, the United Kingdom and the United States. The main conclusion of the meta-analysis stresses the relationship between severe cases of COVID and mental health: People with mental health conditions should be considered a high-risk group, with extra attention paid to disease prevention and management.
The review, published in July 2021, does have some limitations because there aren’t specific demographic breakdowns across the data gleaned from all seven countries, and there were differing definitions of mental health issues. However, it appears that the risk for poor COVID-19 outcomes increases for more severe mental health issues such as schizophrenia and bipolar disorder.
One factor that may play a role in these findings is that many people with mental health conditions also have medical conditions that elevate their COVID-19 risk. These include diabetes, chronic obstructive respiratory disease (COPD), hypertension, and weight problems.
In addition, people with mental health conditions may not have the socioeconomic resources or access to care within their communities, which also increases their risk. These barriers to care can also increase their risk for contracting COVID-19 and suffering intense symptoms.
The study has its limitations, but still, it is another reminder that taking care of your mental health is especially important during the COVID-19 pandemic.
People with recurrent major depressive episodes may be more vulnerable to severe COVID-19, but study results aren’t clear on the relationship between the two. In fact, the researchers behind this review stated that more research is needed on this topic. The data reviewed in this analysis is from the pandemic’s first wave and doesn’t reflect current numbers. Studies also need to be conducted to clarify the association between high COVID risk and other conditions such as depression, anxiety and personality disorders. Finally, study parameters were different in each country, so it’s difficult to make clear-cut extrapolations.
What the data does make clear is that it’s imperative to care for your mental health during the COVID-19 pandemic.
Depression is a risk factor for anxiety and panic attacks, especially during times of stress such as the pandemic. It's a normal, understandable response, and one that calls for immediate treatment as soon as possible.
With the COVID-19 pandemic, depression and anxiety are on the rise. First line treatments include medications and/or talk therapy. If those options don’t work, consider TMS treatment.
And don’t forget to take care of your physical health. Acute or chronic illnesses can raise the risk of contracting COVID-19. Keep up with regular doctor appointments, adhere to healthy lifestyle habits such as regular exercise and a nutritious diet and don’t skip screenings that may provide early detection for diseases such as colon or breast cancer.
Do you need to explore the relationship between TMS and mental health as a way to get through the COVID-19 pandemic? TMS treatment helps with major depressive disorder as well as obsessive compulsive disorder and depression-related anxiety. Our clinic is committed to providing a safe environment for TMS treatment, which includes enhanced cleaning and safety protocols and virtual care options. Take the time to take care of yourself, and schedule your free consultation today.
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.